Partner Article

Wirral's Biofortuna raise £1.3m for expansion

Wirral-based molecular diagnostics outfit, Biofortuna, has raised £1.3m to expand its manufacturing.

The funding was supported by the company’s current investors, including the Foresight Group (UK), Enterprise Ventures Group, Catapult Venture Managers, Merseyside Special Investment Fund, private investors and management.

It will be used to expand Biofortuna’s analysis of freeze drying diagnostic products.

The Bromborough-based business has developed technology that allows DNA tests to be premixed and freeze dried, for a simpler and cost effective process.

Dr Simon Douglas, CEO of Biofortuna said: “This investment will enable Biofortuna to grow its freeze dried development and manufacturing capacity.

“With an increasing number of companies coming to us to stabilise their products we need to expand our freeze drying capability to complement our already established diagnostic development expertise.

“I am delighted that Biofortuna has received continued support from its current investors who share the enthusiasm and vision of the management team.”

This was posted in Bdaily's Members' News section by Tom Keighley .